In fact, data from the three clinical laboratory centers showed higher frequency of the AC-4a pattern in samples that had anti-SS/A-Ro and anti-SS-B/La antibodies than in those with anti-SS-A/Ro only. This evidence concerns the gene CALR and synovial sarcoma.